Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course
NCT ID: NCT03740438
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
154 participants
OBSERVATIONAL
2018-09-01
2023-09-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.
NCT03249038
Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery
NCT01457586
SvO2 Trigger in Transfusion Strategy After Cardiac Surgery
NCT02761564
Moderate Bleeding in Cardiac Surgery Post Operative
NCT02712879
Intra-operative Monitoring of Blood Loss
NCT01864980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemoglobin concentration
Perioperative hemogloin concentration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Requirement for surgical gauzes during surgery, including conversion to open surgical techniques.
* Transfusion of red blood cells (RBCs) or use of blood recovery systems during the perioperative period.
* Significant postoperative bleeding (\> 50 ml in surgical drains, gross hematuria, or any other type of significant blood loss).
* Postoperative hemodynamic instability (defined as requirement of vasoactive drugs).
* Other major postoperative complications during the observable period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sebastian Jaramillo
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinic de Barcelona
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCB/2016/0906/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.